News

All at Pharmetheus wish you God Jul & Gott Nytt År! We are pleased and privileged to have collaborated with many and varied clients throughout 2021 and to have advanced our collective

We are looking for a working Manager for our Quality Control Reviewer – Medical Writing team. Do you want to be part of this inspiring work environment where you get challenged and

With financing from Sweden’s innovation agency (Vinnova), Pharmetheus is increasing its engagement in the development of quantitative approaches to improve chances of clinical success and facilitate risk mitigation in the development of

You are very welcome to join our free webinar on PBPK in January, hosted by GMP and presented by Pharmetheus In this webinar, Tobias Kanacher, Senior Consultant at Pharmetheus, will show you how you can

Modeling and simulation has played an important role in supporting regulatory approvals of caplacizumab for treatment of acquired thrombotic thrombocytopenic purpura (aTTP). For example, in 2018 the EMA agreed that clinical studies

We are very happy to welcome Moriah Pellowee, Associate Consultant, in our team. Moriah’s research experience includes physiological based pharmacokinetic modeling (PBPK), mechanistic modelling of inhaled drugs, development of a virtual bioequivalence

We, at Pharmetheus, congratulate all 2021 ISoP Fellows Jonathan French, Lena Friberg, Siv Jönsson & Saroja Ramanujan who so clearly deserve this recognition for their professional excellence, sustained and substantial impact in

Can one describe tumor and host body responses to the epidermal growth factor receptor-tyrosine kinase inhibitor gefitinib and the MET inhibitors capmatinib and S49076 in mono- and combination therapies? Read the collaboration paper

Pharmetheus is offering virtual professional consulting sessions (~30 min), free of charge, between the 3rd to 17th of November, in connection to the ACoP 12, 2021 meeting. Note that these sessions are open to